Bravado Labs Delay Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Bravado Labs Delay Cream
Generic name: BENZOCAINE
Manufacturer: Prodigy Media Inc
Product type: HUMAN OTC DRUG
SPL set ID: 57269544-9cfb-4ff0-e063-6394a90adb02
SPL ID: 57269544-9cfc-4ff0-e063-6394a90adb02
Version: 1
Effective date: 2026-07-24
Source export date: 2026-10-27
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/b7a5e61d87a3b8f87f4c3ff7b526bfbf6baf84c840f565574c7d83d4083e2b38/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:50:20

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Bravado Labs Delay Cream	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		Prodigy Media Inc	openfda.manufacturer_name
ndc	package	70171-0041-1	openfda.package_ndc
ndc	product	70171-0041	openfda.product_ndc
ndc11	package	70171004101	derived:openfda.package_ndc
spl id		57269544-9cfc-4ff0-e063-6394a90adb02	id
spl set id		57269544-9cfb-4ff0-e063-6394a90adb02	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Avoid contact with eyes Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor Stop use and ask doctor if . If you or your partner develops a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.